| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4644a074805c231782294fe337da60c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11026 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca8a3fe26a9b027a20e7147bb410af2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9be4484425c6a6a0118f3aafe5c7c606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf33d7fc031ec31221a709749edc61cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c33418219710f09a438ced2fb18e5d |
| publicationDate |
2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210089135-A |
| titleOfInvention |
Recombinant replication-competent virus comprising a coding region for glycogen synthase kinase-3 (GSK3) and a method for killing abnormal cells |
| abstract |
In one aspect, the present invention provides an adenovirus (adenovirus) coding sequence for a glycogen synthase kinase-3 (GSK3) protein operably linked to an expression control sequence ), which can replicate in a host cell contained in the genome and can lyse the host cell, and relates to a recombinant replication competent adenovirus (recombinant replication competent adenovirus). It also relates to means and methods of treating cancer with a coding sequence for a glycogen synthetase kinase-3 (GSK3) protein operably linked to an expression control sequence, particularly preferably in the context of adenoviruses. This work is supported in part by the European Union Horizon 2020 research and innovation programme, Marie-Sklodowska-Curie grant number 643130 became |
| priorityDate |
2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |